Sometimes the effects overlap rather than stack
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg for weight management: a randomised, controlled, phase 1b trial
unexplained yellowing of the skin or whites of the eyes
Women with PCOS have a hormonal imbalance and metabolism problems, with symptoms that include weight gain or difficulty losing weight, according to the Office on Womens Health
menstrual changes are typically a secondary effect of significant weight loss reducing oestrogen levels and disrupting HPO axis signalling
For now, doctors rely on patient reports and clinical experience to guide treatment